Worth Venture Partners, LLC Dexcom Inc Transaction History

Worth Venture Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $40,386 - $78,936	-594 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $11,665 - $16,144	124 Added 26.38%	594 $304,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $6,493 - $8,141	50 Added 11.9%	470 $252,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $44,818 - $60,135	420 New	420 $230,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.